← All trials
NCT05192265
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 20, 2019
- Primary completion
- Dec 23, 2020
- Completion date
- Dec 23, 2020
- First posted
- Jan 14, 2022
- Last posted
- Apr 7, 2022
- Enrollment
- 172
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of IbadanLead sponsor
- Shin Poong PharmaceuticalsCollaborator
- University of IbadanReponsible party - principal investigator
- University of IbadanCollaborator
- University of IbadanSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.